Cisapride-induced prolongation of cardiac action potential and early afterdepolarizations in rabbit Purkinje fibres

British Journal of Pharmacology

Volumn 117, Issue 7, 1996, Pages 1377-1379

  Puisieux, François L ^a   Adamantidis, Monique M ^a   Dumotier, Bérengère M ^a   Dupuis, Bernard A ^a  

^a UNIV LILLE   (France)

Author keywords

Cardiac Purkinje fibres; Cisapride; Class III antiarrhythmic effects; Torsades de Pointes

Indexed keywords

CISAPRIDE; POTASSIUM;

ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PURKINJE FIBER; RABBIT; TORSADE DES POINTES;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CISAPRIDE; ELECTROPHYSIOLOGY; HEART; PIPERIDINES; POTASSIUM; PURKINJE FIBERS; RABBITS; TORSADES DE POINTES;

EID: 0029997359     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15295.x     Document Type: Article

References (7)

1. ADAMANTIDIS, M.M., LACROIX, D.L., CARON, J.F. & DUPUIS, B.A. (1995). Electrophysiological and arrhythmogenic effects of the histamine type 1-receptor antagonist astemizole on rabbit Purkinje fibres: clinical relevance. J. Cardiovasc. Pharmacol., 26, 319-327.
2. AHMAD, S.R. & WOLFE, S.M. (1995). Cisapride and torsades de pointes. Lancet, 345, 508.
3. ANTZELEVITCH, C. & SICOURI, S. (1994). Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and Torsades de Pointes. J. Am. Coll. Cardiol., 23, 259-277.
4. BRAN, S., MURRAY, W.A., HIRSCH, A.B. & PALMER, J.P. (1995). Long QT syndrome during high-dose cisapride. Arch. Intern. Med., 155, 765-768.
5. HONDEGHEM, L.M. & SNYDERS, D.J. (1990). Class III antiarrhythmic agents have a lot of potential but a long way to go: reduced effectiveness and dangers of reverse use-dependence. Circulation, 81, 686-690.
6. MCCALLUM, R.W., PRAKASH, C., CAMPOLI-RICHARDS, D.M. & GOA, K.L. (1988). Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs, 36, 652-681.
7. SURAWICZ, B. (1989). Electrophysiologic substrate of torsades de pointes: dispersion of repolarization or early afterdepolarizations? J. Am. Coll. Cardiol., 14, 172-184.